Largest health care pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 health care pharmaceutical companies ranked by net assets, at CHF 72.8B, ahead of Johnson & Johnson (CHF 68.7B) and Sanofi (CHF 66.7B). Figures as of 19 Nov 2026, 10:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerCHF 72.8B
- Median
- CHF 739.8M
- Combined market value
- CHF 4.26T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | CHF 72.8B | CHF 134.7B | CHF 23.64 | 1.44% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | CHF 68.7B | CHF 553B | CHF 229.73 | 2.15% down | 38% up | ||
| 3 | SanofiSNY · Health Care | CHF 66.7B | CHF 95.3B | CHF 39.69 | 0.86% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | CHF 44.3B | CHF 286.1B | CHF 116.07 | 3.90% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | CHF 43.9B | CHF 152.4B | CHF 88.02 | 0.22% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | CHF 41B | CHF 233.6B | CHF 150.59 | 1.93% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | CHF 39.2B | CHF 57.2B | CHF 17.92 | 1.71% down | 54% up | ||
| 8 | NovartisNVS · Health Care | CHF 38.9B | CHF 246.9B | CHF 130.75 | 2.46% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | CHF 26.3B | CHF 82.4B | CHF 796.53 | 1.28% down | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | CHF 24.3B | CHF 146.4B | CHF 33.22 | 3.12% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | CHF 22.4B | CHF 1.04T | CHF 1,164.86 | 2.32% down | 35% up | ||
| 12 | GSKGSK · Health Care | CHF 18.3B | CHF 82B | CHF 40.92 | 1.34% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | CHF 15.7B | CHF 114.6B | CHF 451.92 | 0.42% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | CHF 15.6B | CHF 102.6B | CHF 50.17 | 2.92% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | CHF 12.4B | CHF 19.6B | CHF 17.08 | 0.83% down | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | CHF 8.2B | CHF 33.3B | CHF 57.85 | 0.01% down | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 6.7B | CHF 41.5B | CHF 35.58 | 0.92% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | CHF 6B | CHF 20.7B | CHF 486.36 | 1.16% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | CHF 5.5B | CHF 11.2B | CHF 22.49 | 3.29% up | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | CHF 5.1B | CHF 10B | CHF 51.75 | 4.99% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | CHF 4.9B | CHF 4.9B | CHF 7.14 | 1.85% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | CHF 4.9B | CHF 26.5B | CHF 42.94 | 1.91% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | CHF 3.8B | CHF 23.6B | CHF 32.63 | 0.05% up | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | CHF 3.7B | CHF 38.8B | CHF 340.00 | 2.34% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | CHF 3.6B | CHF 13.4B | CHF 208.73 | 2.93% up | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 3.4B | CHF 10.5B | CHF 12.62 | 1.28% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | CHF 2.8B | CHF 29.3B | CHF 72.09 | 2.50% up | 29% down | ||
| 28 | AlkermesALKS · Health Care | CHF 1.5B | CHF 6.6B | CHF 39.47 | 3.08% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | CHF 856.9M | CHF 5B | CHF 251.64 | 1.67% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | CHF 844.2M | CHF 2.7B | CHF 13.69 | 0.87% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | CHF 739.8M | CHF 7.2B | CHF 257.10 | 0.04% up | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | CHF 664.8M | CHF 16.9B | CHF 125.86 | 4.54% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | CHF 649.1M | CHF 5.3B | CHF 131.61 | 0.94% down | 31% up | ||
| 34 | InsmedINSM · Health Care | CHF 622.5M | CHF 22.1B | CHF 100.92 | 1.69% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | CHF 602.5M | CHF 8.1B | CHF 85.47 | 8.15% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | CHF 555M | CHF 7.1B | CHF 8.85 | 1.59% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | CHF 545.9M | CHF 8.4B | CHF 55.70 | 5.44% up | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | CHF 545.7M | CHF 6.3B | CHF 57.11 | 3.25% down | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | CHF 536.1M | CHF 4.1B | CHF 23.43 | 0.14% down | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | CHF 517.8M | CHF 7B | CHF 107.12 | 2.00% up | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 507.7M | CHF 7.8B | CHF 335.35 | 5.67% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 478.2M | CHF 6.3B | CHF 80.07 | 0.06% down | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | CHF 440M | CHF 3.8B | CHF 34.85 | 1.59% down | 88% up | ||
| 44 | ABIVAXABVX · Health Care | CHF 425.5M | CHF 6.2B | CHF 70.62 | 2.11% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | CHF 415.7M | CHF 4B | CHF 70.75 | 3.45% down | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | CHF 412M | CHF 3.8B | CHF 23.07 | 1.59% up | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | CHF 397.6M | CHF 5.5B | CHF 80.65 | 0.60% down | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 392.6M | CHF 5.1B | CHF 36.32 | 0.28% up | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | CHF 280M | CHF 3.4B | CHF 24.53 | 0.88% down | 169% up | ||
| 50 | ErascaERAS · Health Care | CHF 273.9M | CHF 4.1B | CHF 11.59 | 0.94% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | CHF 265.1M | CHF 5.1B | CHF 77.92 | 0.59% up | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 117.2M | CHF 7B | CHF 100.28 | 2.08% up | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | CHF 96.7M | CHF 4.1B | CHF 42.32 | 1.68% down | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | CHF 74.4M | CHF 5.9B | CHF 112.88 | 1.43% down | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -CHF 59.6M | CHF 6.4B | CHF 18.43 | 3.60% up | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -CHF 101.9M | CHF 4.4B | CHF 105.18 | 0.62% down | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -CHF 152.2M | CHF 14.9B | CHF 227.73 | 0.32% down | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -CHF 173M | CHF 4.2B | CHF 50.74 | 0.22% down | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -CHF 555.7M | CHF 6B | CHF 43.23 | 0.64% down | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -CHF 1.8B | CHF 12.8B | CHF 65.72 | 1.58% up | 17% up | ||
| 61 | AbbVieABBV · Health Care | -CHF 2.8B | CHF 425.9B | CHF 240.94 | 2.33% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8424 CHF).
Questions and answers
Which health care pharmaceutical companies rank first by net assets?
Pfizer (CHF 72.8B), Johnson & Johnson (CHF 68.7B) and Sanofi (CHF 66.7B) are the top three of the 61 health care pharmaceutical companies ranked by net assets as of 19 Nov 2026, 10:23 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by net assets have a combined market value of CHF 4.26T as of 19 Nov 2026, 10:23 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.